1-1340424-G-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_001330311.2(DVL1):​c.685C>G​(p.Arg229Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000404 in 1,612,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R229P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00041 ( 0 hom. )

Consequence

DVL1
NM_001330311.2 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.06

Publications

6 publications found
Variant links:
Genes affected
DVL1 (HGNC:3084): (dishevelled segment polarity protein 1) DVL1, the human homolog of the Drosophila dishevelled gene (dsh) encodes a cytoplasmic phosphoprotein that regulates cell proliferation, acting as a transducer molecule for developmental processes, including segmentation and neuroblast specification. DVL1 is a candidate gene for neuroblastomatous transformation. The Schwartz-Jampel syndrome and Charcot-Marie-Tooth disease type 2A have been mapped to the same region as DVL1. The phenotypes of these diseases may be consistent with defects which might be expected from aberrant expression of a DVL gene during development. [provided by RefSeq, Jul 2008]
DVL1 Gene-Disease associations (from GenCC):
  • autosomal dominant Robinow syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant Robinow syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.079295814).
BP6
Variant 1-1340424-G-C is Benign according to our data. Variant chr1-1340424-G-C is described in ClinVar as Benign. ClinVar VariationId is 599454.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 57 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001330311.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DVL1
NM_001330311.2
MANE Select
c.685C>Gp.Arg229Gly
missense
Exon 6 of 15NP_001317240.1
DVL1
NM_004421.3
c.685C>Gp.Arg229Gly
missense
Exon 6 of 15NP_004412.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DVL1
ENST00000378888.10
TSL:5 MANE Select
c.685C>Gp.Arg229Gly
missense
Exon 6 of 15ENSP00000368166.5
DVL1
ENST00000378891.9
TSL:1
c.685C>Gp.Arg229Gly
missense
Exon 6 of 15ENSP00000368169.5
DVL1
ENST00000633096.1
TSL:4
n.-59C>G
upstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.000374
AC:
57
AN:
152256
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000720
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000303
AC:
74
AN:
244568
AF XY:
0.000331
show subpopulations
Gnomad AFR exome
AF:
0.000193
Gnomad AMR exome
AF:
0.0000588
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000623
Gnomad NFE exome
AF:
0.000482
Gnomad OTH exome
AF:
0.000506
GnomAD4 exome
AF:
0.000407
AC:
594
AN:
1460048
Hom.:
0
Cov.:
36
AF XY:
0.000406
AC XY:
295
AN XY:
726232
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33464
American (AMR)
AF:
0.0000450
AC:
2
AN:
44430
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26052
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39650
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86068
European-Finnish (FIN)
AF:
0.000586
AC:
31
AN:
52934
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5764
European-Non Finnish (NFE)
AF:
0.000483
AC:
537
AN:
1111414
Other (OTH)
AF:
0.000282
AC:
17
AN:
60272
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000374
AC:
57
AN:
152256
Hom.:
0
Cov.:
34
AF XY:
0.000350
AC XY:
26
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41464
American (AMR)
AF:
0.0000654
AC:
1
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000720
AC:
49
AN:
68044
Other (OTH)
AF:
0.000478
AC:
1
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000359
Hom.:
0
Bravo
AF:
0.000227
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000289
AC:
35

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 15, 2017
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1, BS2, BP1, BP4; This alteration has an allele frequency that is greater than expected for the associated disease, was seen in a healthy adult where full penetrance of the disorder is expected at an early age, is a missense alteration in a gene for which primarily truncating variants are known to cause disease, and is predicted to be tolerated by multiple functional prediction tools.

DVL1-related disorder Benign:1
May 10, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

not provided Benign:1
Nov 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.45
T
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.75
D
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.079
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.6
L
PhyloP100
2.1
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.026
Sift
Benign
0.088
T
Sift4G
Benign
0.13
T
Polyphen
0.23
B
Vest4
0.50
MVP
0.74
MPC
0.13
ClinPred
0.021
T
GERP RS
2.7
PromoterAI
-0.042
Neutral
Varity_R
0.097
gMVP
0.23
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144365982; hg19: chr1-1275804; API